Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats

European Journal of Pharmacology
Rossella RotaP Hannaert

Abstract

Calcium dobesilate stabilizes blood-retinal barrier in patients with diabetic retinopathy and possesses antioxidant properties in the retinas of rats with streptozotocin-induced diabetes, exposed ex vivo to ischemia-reperfusion. Here we investigated the action of calcium dobesilate on retinal albumin leakage in streptozotocin-diabetic rats, together with relevant in vivo retinal antioxidant and permeability markers, i.e., carboxymethyl-lysine-advanced glycation end product (CML-AGE) formation and vascular endothelial cell growth factor (VEGF) overexpression. Twenty days after streptozotocin administration, diabetic rats were treated for 10 days with calcium dobesilate (100 mg/kg/day per os) or vehicle. Retinal albumin leakage, CML-AGE formation, and VEGF overexpression were evaluated by immunohistochemistry of frozen eye sections. Diabetic rats exhibited dramatic increases in: (i) retinal albumin leakage (31% of positive vessels vs. 0.2% in nondiabetic rats, P<0.008), (ii) CML-AGE retinal occurrence (40+/-3% vs. undetectable positive vessels), and (iii) retinal VEGF protein expression (14.6+/-1.1 vs. 3.5+/-0.5 VEGF-positive spots/field, P<10(-4)). Calcium dobesilate significantly reduced: (i) retinal albumin leakage (by 70%, P<...Continue Reading

References

Jan 1, 1979·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·F M GrignoloF Sebastiani
Jan 1, 1975·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·B NémethA Farkas
Mar 1, 1990·International Ophthalmology·E B LeiteJ G Cunha-Vaz
Jan 1, 1981·Current Eye Research·O P van Bijsterveld, P T Janssen
Jul 30, 1997·Biochemical and Biophysical Research Communications·C HirataM Kondo
Jan 22, 1998·Free Radical Biology & Medicine·E A EllisG A Lutty
Apr 29, 1998·The Journal of Clinical Investigation·M LuA P Adamis
May 5, 1998·Fundamental & Clinical Pharmacology·J BrunetP Hannaert
Jul 14, 1998·Journal of Toxicology and Environmental Health. Part a·N H AnsariA Mansour
Dec 8, 1998·The International Journal of Angiology : Official Publication of the International College of Angiology, Inc·G A LosaJ C Farine
Apr 12, 2000·Seminars in Ophthalmology·D A AntonettiT W Gardner
Jul 7, 2001·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·M EndoT Koike
Sep 26, 2001·The Journal of Biological Chemistry·C TreinsE Van Obberghen
Oct 25, 2001·European Journal of Pharmacology·M E SzaboR P Garay
Jan 5, 2002·Expert Opinion on Investigational Drugs·R A Kowluru, A Kennedy
Jan 19, 2002·Biochemical and Biophysical Research Communications·Sho-ichi YamagishiZenji Makita
Mar 6, 2003·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Yasuhiko YamamotoHiroshi Yamamoto
Apr 26, 2003·BMJ : British Medical Journal·Peter J Watkins
Jul 2, 2003·Experimental and Molecular Pathology·Alan W Stitt
Dec 4, 2003·Diabetes/metabolism Research and Reviews·Ruth B CaldwellR William Caldwell

❮ Previous
Next ❯

Citations

Jun 7, 2005·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Xiaocheng Liu, Xinming Liu
Jun 10, 2006·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Maria L RibeiroUNKNOWN DX-Retinopathy Study Group
Mar 3, 2005·European Journal of Pharmacology·Stéphane LameynardieNúria Parés-Herbuté
Dec 23, 2006·Antioxidants & Redox Signaling·Mayumi YamatoHideo Utsumi
Aug 2, 2005·Treatments in Endocrinology·Ricardo P GarayCarlo Chiavaroli
Jun 2, 2010·International Journal of Molecular Medicine·Irina G ObrosovaCarl-David Agardh
Aug 6, 2005·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Roja RahimiMohammad Abdollahi
May 6, 2015·Progress in Retinal and Eye Research·Rafael Simó, Cristina Hernández
Feb 9, 2017·Pharmacology & Therapeutics·Christine T O NguyenMagnus Ivarsson
Jun 3, 2017·Current Eye Research·Cristina Solà-AdellRafael Simó
Jan 18, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Liming JinR Clinton Webb
May 12, 2007·American Journal of Physiology. Renal Physiology·Constance Temm, Jesus H Dominguez
Dec 4, 2019·Frontiers in Neuroscience·Maria Grazia RossinoGiovanni Casini
Feb 29, 2020·Pharmacology & Therapeutics·Ana Raquel SantiagoAntónio Francisco Ambrósio
Oct 16, 2020·Naunyn-Schmiedeberg's Archives of Pharmacology·Gholamreza BazmandeganMorteza Amirteimoury
Feb 16, 2019·Life Sciences·Jie LiuDong Sun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis